Figure 6.
Figure 6. Effects of TK inhibitors on expression of cell-surface antigens on HMC-1.2 cells. (A) HMC-1.2 cells were exposed to control medium (Co, □), PKC412, 1 μM (▪), AMN107, 1 μM (▨), or imatinib, 1 μM (▦) at 37°C for 24 hours. After incubation, cells were examined for expression of various CD antigens by flow cytometry using CD-specific mAbs. The figure shows the mean fluorescence intensity (MFI) levels as percent of control (Co, □). Results represent the mean ± SD of 3 independent experiments. *P < .05 compared with control. (B) Dose-dependent effect of PKC412 on expression of CD63 in HMC-1.2 cells. Cells were incubated with various concentrations of PKC412 as indicated at 37°C for 24 hours. Cells were then examined for expression of CD63 by flow cytometry. As visible, PKC412 dose dependently decreased expression of CD63.

Effects of TK inhibitors on expression of cell-surface antigens on HMC-1.2 cells. (A) HMC-1.2 cells were exposed to control medium (Co, □), PKC412, 1 μM (▪), AMN107, 1 μM (▨), or imatinib, 1 μM (▦) at 37°C for 24 hours. After incubation, cells were examined for expression of various CD antigens by flow cytometry using CD-specific mAbs. The figure shows the mean fluorescence intensity (MFI) levels as percent of control (Co, □). Results represent the mean ± SD of 3 independent experiments. *P < .05 compared with control. (B) Dose-dependent effect of PKC412 on expression of CD63 in HMC-1.2 cells. Cells were incubated with various concentrations of PKC412 as indicated at 37°C for 24 hours. Cells were then examined for expression of CD63 by flow cytometry. As visible, PKC412 dose dependently decreased expression of CD63.

Close Modal

or Create an Account

Close Modal
Close Modal